14:50 EST Revolution Medicines (RVMD) near deal to be bought by AbbVie (ABBV), WSJ says
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RVMD:
- Revolution Medicines trading halted, volatility trading pause
- Erasca initiated with an Overweight at Piper Sandler
- Revolution Medicines price target raised to $98 from $82 at BofA
- Revolution Medicines Advances Daraxonrasib Into Phase 3 Pancreatic Cancer Trial, Extending Long-Term Upside Potential
- These Are the Most and Least Likely Biotech Takeover Targets for 2026